الفهرس | Only 14 pages are availabe for public view |
Abstract Acne vulgaris is a multifactorial chronic inflammatory disorder of the pilosebaceous follicles of human skin (54). Interleukin 19 is a member of the IL-10 family of cytokines which includes IL-10, IL-19, IL-20, IL-22, IL-24 and IL-26 (84). The present research was intended to evaluate the interleukin-19 serum levels and gene polymorphism in acne vulgaris patients and their correlation to disease severity. This case control study was conducted on total number 90 patients with different clinical varity of acne vulgaris and 90 age and sex matched healthy subjects as control group. The result of the current study showed that: Interlukin-19 serum levels showed statistically significant higher mean values in acne vulgaris patients than the control group (122.1±115.9 pg/ml vs. 32.2±22.3pg/ml) (p = 0.001). Also, there was significant association between serum level of IL 19 and severity of acne vulgaris. Studying the relation between IL-19 serum levels and studied sociodemographic and clinical criteria of acne patients revealed nonsignificant correlations or associations except for onset of AV disease (P=0.036). Regarding IL-19 C/T polymorphism, TT genotype was significantly higher in AV cases (41, 45.6 %) than in controls ( 13, 14.4%) with 13.6 OR, as well CT genotype was observed in cases than controls with 6.4 OR (P = 0.001). Additionally, IL-19 T allele was significantly reported in acne vulgaris cases than controls (66.1% vs.28.3%) (P = 0.001). Summary 70 Studying the relation between IL-19 C/T genotypes with sociodemographic and clinical data of acne patients, there was statistical significant difference between different IL 19 genotype and progressive course, duration of disease and type of acne (P < 0.05). However, there was non-statistical significant difference between different IL 19 genotype with age, gender, onset and family history of the disease (P>0.05). Relationship between IL 19 genotype and serum level, IL 19 serum level was significantly higher in patients with genotype TT than in those with genotype CC (P2 = 0.002), also IL 19 serum level in patients with genotype CT than in those with genotype CC (p3 = 0.001). However there was non-statistical significant difference between patients with genotype TT and CT regarding IL 19 serum level (p1 = 0.085). |